Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · IEX Real-Time Price · USD
9.94
-0.13 (-1.29%)
Jul 22, 2024, 10:02 AM EDT - Market open
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 122 employees as of December 31, 2023. The number of employees decreased by 62 or -33.70% compared to the previous year.
Employees
122
Change (1Y)
-62
Growth (1Y)
-33.70%
Revenue / Employee
$5,878
Profits / Employee
-$1,024,081
Market Cap
262.86M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Auna SA | 14,958 |
MultiPlan | 2,800 |
Viemed Healthcare | 996 |
Tenaya Therapeutics | 140 |
Nektar Therapeutics | 137 |
Monte Rosa Therapeutics | 133 |
Zentalis Pharmaceuticals | 124 |
Sanara MedTech | 108 |
INO News
- 11 days ago - INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway - PRNewsWire
- 19 days ago - INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer - PRNewsWire
- 20 days ago - INOVIO Reports Inducement Grant Under Inducement Plan - PRNewsWire
- 21 days ago - INOVIO Added to Russell 2000® Index Effective July 1, 2024 - PRNewsWire
- 6 weeks ago - INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. - PRNewsWire
- 7 weeks ago - INOVIO Reports Inducement Grants Under Inducement Plan - PRNewsWire
- 2 months ago - INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire
- 3 months ago - INOVIO to Participate in Upcoming Investor Conferences in May - PRNewsWire